TickerFactsScreenerDevelopers

Aquestive Therapeutics, Inc. (AQST) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$113.0K2018: -$48.93M2019: -$52.67M2020: -$42.89M2021: -$34.68M2022: -$42.07M2023: -$15.10M2024: -$30.77M2025: -$71.05M-$71.05M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$71.05M-130.9%
2024-$30.77M-103.8%
2023-$15.10M+64.1%
2022-$42.07M-21.3%
2021-$34.68M+19.1%
2020-$42.89M+18.6%
2019-$52.67M-7.6%
2018-$48.93M-43204.4%
2017-$113.0K—